Nexalin Technology, Inc. (NASDAQ:NXL) Shares Shorted: Short Interest Up 180.7% in October

Nexalin Technology, Inc. (NASDAQ:NXL – Get Free Report) saw a large increase in short interest in October. As of October 30th, there was short interest totaling 12,581 shares, an increase of 180.7% from the October 15th total of 4,482 shares. Approximately 2.1% of the company’s shares are short sold. Based on an average daily volume of 59,806 shares, the short-interest ratio is currently 0.2 days.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Zacks Research raised shares of Nexalin Technology to a “hold” rating in a research note on Thursday, October 1st. Weiss Ratings downgraded shares of Nexalin Technology from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, September 25th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Nexalin Technology currently has a consensus rating of “Reduce”.

Check Out Our Latest Report on Nexalin Technology

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Nexalin Technology stock. PEAK6 LLC bought a new stake in Nexalin Technology, Inc. (NASDAQ:NXL – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 240,210 shares of the company’s stock, valued at approximately $79,000. PEAK6 LLC owned about 1.09% of Nexalin Technology at the end of the most recent quarter. Hedge funds and other institutional investors own 0.65% of the company’s stock.

Nexalin Technology Price Performance

NXL stock traded down $0.01 on Friday, hitting $1.48. 16,514 shares of the company were exchanged, compared to its average volume of 43,064. The stock has a market capitalization of $1.08 million, a price-to-earnings ratio of -0.11 and a beta of 4.31. Nexalin Technology has a twelve month low of $1.31 and a twelve month high of $35.53. The business’s fifty day moving average is $3.34 and its two-hundred day moving average is $10.10.

Nexalin Technology (NASDAQ:NXL – Get Free Report) last announced its quarterly earnings results on Thursday, November 12th. The company reported ($3.43) earnings per share for the quarter, missing analysts’ consensus estimates of ($2.91) by ($0.52). Nexalin Technology had a negative net margin of 3,384.12% and a negative return on equity of 344.93%. The company had revenue of $0.08 million during the quarter, compared to analyst estimates of $0.07 million. Equities research analysts expect that Nexalin Technology will post -11.42 earnings per share for the current year.

Nexalin Technology Company Profile

(Get Free Report)

Nexalin Technology, Inc. (NASDAQ:NXL) is a medical technology company focused on developing and commercializing noninvasive neurostimulation devices for mental health and neurological applications. Its technology is designed to deliver low-intensity electrical stimulation to the brain with the goal of influencing neural activity associated with conditions such as depression, anxiety, insomnia, post-traumatic stress disorder and substance-use disorders. The company’s product portfolio includes the Gen-2 and Gen-3 neurostimulation systems.

Featured Stories

Receive News & Ratings for Nexalin Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexalin Technology and related companies with MarketBeat.com's FREE daily email newsletter.